Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesClinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension
Journal of Human Hypertension, 11/04/09
Sato A et al. - There were no significant correlations between plasma renin activity or plasma aldosterone concentration (PAC) before eplerenone treatment and blood pressure after eplerenone treatment, showing that the antihypertensive effect of eplerenone is not affected by the patient's renin profile or pretreatment PAC values. Eplerenone was also effective in hypertensive patients with metabolic syndrome. In conclusion, eplerenone, when coadministered with an ACE inhibitor or a long-acting CCB, caused an extremely beneficial antihypertensive effect in Japanese patients with essential hypertension, without few clinically important adverse events.
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Managing Peripheral Edema in Patients With Arterial Hypertension
American Journal of Therapeutics, 11/25/09
Health Care Services Provided During Physician Office Visits for Hypertension: Differences by Specialty
The Journal of Clinical Hypertension, 11/25/09
Efficacy of an Olmesartan Medoxomil–Based Treatment Algorithm in Patients Stratified by Age, Race, or Sex
The Journal of Clinical Hypertension, 11/25/09
Article Search
Sponsor